Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
FDG PET-CT imaging in assessing interim response...
Journal article

FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.

Abstract

460 Background: Muscle invasive bladder cancer (MIBC) is an aggressive local disease where initial staging with conventional CT imaging is often suboptimal. To explore the role of PET-CT in both staging MIBC and assessing response to neoadjuvant chemotherapy (NAC), we conducted a prospective multicentre, randomized trial known as PETMUSE. We report here the first results from the neoadjuvant substudy which assessed interim …

Authors

Sridhar SS; Power N; Breau RH; Cheng SY; Pond GR; Chung PWM; Metser U; Levine MN; Mukherjee SD

Journal

Journal of Clinical Oncology, Vol. 41, No. 6_suppl, pp. 460–460

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

February 20, 2023

DOI

10.1200/jco.2023.41.6_suppl.460

ISSN

0732-183X